Elle this year arguably saved the best for last. Both the print and online layouts for the magazine’s August issue highlighting of tech-industry female superstars, sub-headlined “Star Tech Voyagers,” closes with Piraye Yurttas Beim, founder and CEO of New York biotech company Celmatix.
For starters, the company’s new blood test Fertilome, a multi-gene test that outlines a woman’s reproductive health, was released in January. Another Celmatix product, the software program Polaris, relies on the largest clinical data-set of fertility treatment outcomes.
Then there is the relevance of the company’s mandate to its progenitor:
At 32, just married and in the midst of getting Celmatix off the ground, Beim was diagnosed with diminished ovarian reserves. Knowing she’d soon lose the ability to have children, Beim had three in four years. “My investors have rarely seen me not pregnant,” she says. …
This first-hand experience informs her advocacy for testing patients’ fertility before they become one of the 7.5 million American women struggling to conceive. “It’s not theoretical for me,” she says. “It’s personal.”
Elle editor in chief Robbie Meyer feted the 2017 “Women in Tech” honorees at a July 12 dinner in San Francisco. Others on the list include Sequoia Capital partner Jess Lee, Stanford University Artificial Intelligence Lab director Fei-Fei Li and Amazon vice president Maria Renz.
The original version of this item misspelled Beim’s middle name and included an incorrect description of Fertilome. Fishbowl apologizes for the errors.